SmB café 10 Oct '13 - ZoBio - Gregg Siegal, Dipen Shah
Click here to load reader
-
Upload
christiaan-van-gorkum -
Category
Technology
-
view
181 -
download
2
description
Transcript of SmB café 10 Oct '13 - ZoBio - Gregg Siegal, Dipen Shah
Spinning Fragments Into Lead Molecules: A New Impulse in Fragment-Based Drug DiscoverySpinning Fragments Into Lead Molecules: A New Impulse in Fragment-Based Drug Discovery
Gregg SiegalZoBio
ZoBio Corporate OverviewZoBio Corporate Overview
Founded as Dutch BV 11/2004
Full access to all lab facilities of UL including 600 & 850 MHz NMR spectrometers
Self funded (grants and commercial activities)
10 employees
Customers: 9 of 15 largest pharma, many medium pharma and biotech
Business model:
Primarily Fee-for-Service
Limited internal discovery via academic collaboration
Projects typically completed in 1-2 months
www.zobio.com
Role in ZoBio : CSO & Founder
Key responsibilities:• Scientific Vision• Strategic Planning• Business Development
Background:Ph.D. studentBiochemistry, University of Rochester, USA
Post-Doc1.ETH Zürich, Lab of Prof. Kurt Wüthrich2.Ludwig Institute for Cancer Research, London, Prof. Paul Driscoll
Current AcademicLeiden University, Docent Protein Chemistry group
Gregg Siegal
Ron WesterRon Wester
Role in ZoBio : Post-doctoral Scientist
Key responsibilities:• Cloning, expression and production of protein targets (Bacterial and Insect cell cultures)• Application of isotope labeling for NMR based studies of protein targets • NMR methods to investigate target-small molecule binding• Preparation of a project plan as a part of a quotation to a customer• Reporting research results to customers
Currently involved in:• As a Project Leader for one project• Specific activities in 6 different projects
Background:Ph.D. studentResearch title- Developing efficient NMR methods to investigate protein-small molecule interactionsCo-promoter – Dr. Gregg Siegal; Promoter- Prof.dr.Marcellus UbbinkLeiden Institute of Chemistry, Leiden University
M.Res (Master of Research in Biomedical Sciences)Expression and characterization of GPCRs suitable for biophysical studiesDr. Niall Fraser and Prof. dr. Graeme Milligan (University of Glasgow, U.K)
B.Pharm.Sci (Bachelor’s of Pharmaceutical Sciences)Institute of Chemical Technology, Mumbai, India
Dipen Shah
Ron WesterRon Wester